4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
NervGen Pharma Corp. (NGEN) operates in the Biotechnology industry and is headquartered in Vancouver, Canada with about 9 employees. Its market capitalization is roughly $229 million. In the fiscal year ended 2025-12-31, NGEN reported C$0M in revenue and (C$44M) in net income.
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | C$0M | C$0M | C$0M | C$0M | — |
| Operating Income (EBIT) | (C$25M) | (C$25M) | (C$18M) | (C$23M) | — |
| Net Income | (C$44M) | (C$24M) | (C$22M) | (C$21M) | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | C$0M | C$0M | C$0M | C$0M | C$0M | — | — |
| Operating Income (EBIT) | (C$12M) | (C$8M) | (C$6M) | (C$6M) | (C$6M) | — | — |
| Net Income | (C$29M) | (C$2M) | (C$27M) | (C$4M) | (C$9M) | — | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | C$23M | C$20M | C$13M | C$24M | — |
| Total Liabilities | C$20M | C$17M | C$15M | C$10M | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NGEN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms